Search results
Results from the WOW.Com Content Network
A systematic review did not find any evidence of any benefit in preventing vision loss in eyes treated with triamcinolone acetonide over placebo, for patients with age-related macular degeneration. [18] Triamcinolone acetonide is also administered via intralesional injection in the treatment of hypertrophic and keloid scars. [19] [20]
The side effects of triamcinolone are similar to other corticosteroids. In short-term treatment of up to ten days, it has very few adverse effects; however, sometimes gastrointestinal bleeding is seen, as well as acute infections (mainly viral) and impaired glucose tolerance. [4]
Dementia-like symptoms have been found in some individuals who have been exposed to glucocorticoid medication, often dispensed in the form of asthma, arthritis, and anti-inflammatory steroid medications. The condition reverses, but not always completely, within months after steroid treatment is stopped. [2]
The doctor can look for potential underlying causes, including dementia, medication effects, or environmental factors, Elhelou says. From there, they can suggest effective ways to help you manage ...
2. Eat Smaller, More Frequent Meals. Instead of three main meals, try eating smaller, more frequent meals throughout the day. This can help if nausea is making it hard to feel like eating or if ...
[2] [5] It is given by injection. [6] Side effects are common and include loss of appetite, nausea, muscle pains, headache, and feeling tired. [2] [5] Serious side effect may include an irregular heartbeat or pancreatitis. [5] Sodium stibogluconate is less safe than some other options during pregnancy. [2]
Eli Lilly also offers a diabetes medication, Mounjaro, as well as a version for weight loss, Zepbound. In a new trend, some people are using smaller daily "microdoses" of Ozempic, doctors report.
These side effects are serious and some of them are permanent, and many remain a crucial concern for companies and healthcare professionals and substantial efforts are being encouraged to reduce the potential risks for future antipsychotics through more clinical trials and drug development.